BeStock  

Ironwood Pharmaceuticals IRWD

US equityMarket cap rank #3323Drug Manufacturers - Specialty & Generic
$4.70 −$0.01 (-0.21%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $4.60 -2.13%
Open$4.66
Prev close$4.71
Day range$4.65 – $4.87
Volume3.02M
Market cap$778.09M
P/E (TTM)5.2
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$133.04M+9.0% YoY
Operating profit$93.13M+19.9% YoY
Net profit$59.84M+49.3% YoY
Diluted EPS$0.36+56.5% YoY
Free cash flow$67.40M+41.7% YoY
Operating cash flow$67.40M

Revenue, last 8 quarters

$90.5MDec '24$41.1MMar '25$85.2MJun '25$122.1MSep '25$47.7MDec '25$106.5MMar '26$113.0MJun '26$133.0MSep '26

Net profit, last 8 quarters

$2.3MDec '24$-37.4MMar '25$23.6MJun '25$40.1MSep '25$-2.3MDec '25$40.8MMar '26$51.3MJun '26$59.8MSep '26

Diluted EPS by quarter

0.02Dec '24-0.23Mar '250.14Jun '250.23Sep '25-0.01Dec '250.24Mar '260.31Jun '260.36Sep '26

Free cash flow by quarter

$15.2MDec '24$19.9MMar '25$-15.1MJun '25$47.6MSep '25$74.6MDec '25$5.1MMar '26$58.3MJun '26$67.4MSep '26

Annual revenue

$389.5MFY20$413.8MFY21$410.6MFY22$442.7MFY23$351.4MFY24$296.2MFY25

Profitability & balance sheet

Operating margin62.8%
Net margin37.4%
Return on assets43.6%
Current ratio6.51
Liabilities / assets133.4%
Cash & investments$86.38M
Total debt$332.91M
Net cash (debt)-$246.53M
Free cash flow / sales51.3%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $133.04M $113.04M $106.51M $296.15M $47.71M
Total Operating Revenue $133.04M $113.04M $106.51M $296.15M $47.71M
Operating Expense $39.91M $33.73M $33.97M $177.39M $41.16M
Selling and Admin Expenses $11.55M $11.31M $12.03M $82.26M $19.29M
Research & Development $28.35M $22.42M $21.94M $95.14M $21.86M
Operating Profit $93.13M $79.31M $72.53M $118.76M $6.55M
Net Non-Operating Interest Income (Expense) -$5.58M -$5.62M -$7.44M -$28.67M -$6.43M
Non-Operating Interest Income $619,000.00 $1.59M $1.70M $4.08M $1.46M
Non-Operating Interest Expense $6.20M $7.20M $8.97M $32.75M $7.89M
Other Income (Expense) $41,000.00 $42,000.00 $82,000.00 -$20.06M $329,000.00
Special Income (Charges) $0.00 $0.00 $40,000.00 -$20.26M $252,000.00
-Less:Restructuring and Mergern & Acquisition $0.00 $0.00 -$40,000.00 $20.26M -$252,000.00
Other Non-Operating Income (Expenses) $41,000.00 $42,000.00 $42,000.00 $193,000.00 $77,000.00
Pretax Profit $87.60M $73.73M $65.17M $70.03M $455,000.00
Tax $27.76M $22.44M $24.40M $46.01M $2.73M
Net Profit $59.84M $51.29M $40.77M $24.02M -$2.28M
Profit from Continuing Operations $59.84M $51.29M $40.77M $24.02M -$2.28M
Net Income to Parent Company $59.84M $51.29M $40.77M $24.02M -$2.28M
Net Income to Common Stockholders $59.84M $51.29M $40.77M $24.02M -$2.28M
Basic EPS $0.36 $0.31 $0.25 $0.15 -$0.01
Diluted EPS $0.36 $0.31 $0.24 $0.15 -$0.01
Total Other Finance Costs – – $175,000.00 – –

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $290.59M $285.13M $434.57M $396.90M $396.90M
Total Current Assets $225.99M $199.20M $332.29M $274.18M $274.18M
Cash and Cash Equivalents & Short-Term Investments $86.38M $79.13M $220.47M $215.46M $215.46M
-Cash and Cash Equivalents $86.38M $79.13M $220.47M $215.46M $215.46M
Receivables $132.72M $112.73M $105.84M $46.75M $46.75M
-Accounts Receivable $132.72M $112.73M $105.84M $46.75M $46.75M
Other Current Assets $6.90M $7.34M $5.98M $11.98M $11.98M
Total Non-Current Assets $64.60M $85.93M $102.27M $122.72M $122.72M
Net PPE $10.64M $11.36M $12.06M $12.75M $12.75M
-Gross PPE $10.64M $11.36M $12.06M $20.75M $20.75M
Goodwill and Other Intangible Assets $1.43M $1.63M $1.84M $2.04M $2.04M
-Other Intangible Assets $1.43M $1.63M $1.84M $2.04M $2.04M
Non-Current Deferred Assets $48.94M $69.06M $84.24M $103.43M $103.43M
Other Non-Current Assets $3.60M $3.87M $4.14M $4.50M $4.50M
Total Liabilities $387.79M $446.97M $651.71M $658.74M $658.74M
Total Current Liabilities $34.73M $32.85M $236.31M $242.22M $242.22M
Payables $5.01M $5.19M $7.13M $3.83M $3.83M
-Accounts Payable $3.62M $911,000.00 $3.24M $2.90M $2.90M
-Total Tax Payable $1.39M $4.28M $3.89M $927,000.00 $927,000.00
Current Accrued Expenses $12.81M $12.12M $12.07M $13.36M $13.36M
Short-Term Debt and Capital Lease Obligation $3.30M $3.29M $203.12M $202.93M $202.93M
-Current Capital Lease Obligation $3.30M $3.29M $3.27M $3.25M $3.25M
Current Deferred Liabilities $1.26M $1.25M $1.47M $1.11M $1.11M
Other Current Liabilities $2.41M $3.52M $5.98M $9.41M $9.41M
Total Non-Current Liabilities $353.05M $414.12M $415.40M $416.52M $416.52M
Long Term Debt and Capital Lease Obligation $332.91M $393.58M $394.23M $394.87M $394.87M
-Long Term Debt $325.00M $385.00M $385.00M $385.00M $385.00M
-Long Term Capital Lease Obligation $7.91M $8.58M $9.23M $9.87M $9.87M
Other Non-Current Liabilities $20.14M $20.54M $21.17M $21.65M $21.65M
Total Equity -$97.19M -$161.84M -$217.14M -$261.84M -$261.84M
Stockholders' Equity -$97.19M -$161.84M -$217.14M -$261.84M -$261.84M
Capital Stock $166,000.00 $165,000.00 $165,000.00 $163,000.00 $163,000.00
-Common Stock $166,000.00 $165,000.00 $165,000.00 $163,000.00 $163,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $1.42B $1.42B $1.42B $1.41B $1.41B
Retained Earnings -$1.52B -$1.58B -$1.63B -$1.67B -$1.67B
Gains/Losses Not Affecting Retained Earnings $196,000.00 -$324,000.00 -$795,000.00 -$1.06M -$1.06M
-Current Debt – – $199.86M $199.68M $199.68M
-Accumulated Depreciation – – – -$8.01M -$8.01M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $67.40M $58.28M $5.12M $127.04M $74.58M
Net cash flow from continuing operations $67.40M $58.28M $5.12M $127.04M $74.58M
Net Income from Continuing Operations $59.84M $51.29M $40.77M $24.02M -$2.28M
Depreciation & Depletion & Amortization $459,000.00 $457,000.00 $443,000.00 $1.88M $460,000.00
Deferred Tax $20.13M $15.17M $19.20M $40.80M -$1.75M
Other Non-Cash Items $707,000.00 $842,000.00 $863,000.00 $1.67M -$835,000.00
Change in Working Capital -$18.02M -$12.72M -$59.81M $41.34M $75.15M
-Change in Receivables -$19.99M -$6.89M -$59.10M $35.15M $73.62M
-Change in Prepaid Assets $387,000.00 -$1.42M $6.00M $367,000.00 $1.09M
-Change in Payables and Accrued Expense $2.41M -$3.49M -$5.99M $2.10M -$592,000.00
-Change in Other Current Assets $28,000.00 $17,000.00 $121,000.00 $2.14M $1.79M
-Change in Other Current Liabilities -$860,000.00 -$944,000.00 -$840,000.00 $1.59M -$753,000.00
Net cash flow from investing $0.00 $0.00 $0.00 -$34,000.00 $1,000.00
Net Cash Flow from Continuing Investing Activities $0.00 $0.00 $0.00 -$34,000.00 $1,000.00
Net PPE Purchase and Sale $0.00 $0.00 $0.00 -$34,000.00 $1,000.00
Financing Cash Flow -$60.00M -$199.70M $0.00 $216,000.00 $122,000.00
Net Cash Flow from Continuing Financing Activities -$60.00M -$199.70M $0.00 $216,000.00 $122,000.00
Net Issuance Payments Of Debt -$60.00M – – $0.00 $0.00
Proceeds from Stock Option Exercised $0.00 $303,000.00 $0.00 $216,000.00 $122,000.00
Ending Cash Balance $86.38M $79.13M $220.47M $215.46M $215.46M
Net Change in Cash $7.40M -$141.42M $5.12M $127.23M $74.70M
Beginning Cash Balance $79.13M $220.47M $215.46M $88.56M $140.41M
Effect of Exchange Rate Changes -$152,000.00 $77,000.00 -$106,000.00 -$329,000.00 $351,000.00
Free Cash Flow $67.40M $58.28M $5.12M $127.01M $74.58M
Gain/Loss from Continuing Operations – – – $89,000.00 -$3,000.00

Discussion

No comments yet — be the first to weigh in on IRWD.

Sign in to join the discussion.

Scroll to Top